NCT07075887Not yet recruiting
Optic Nerve Head Evaluation Through Multimodal Blood Flow Analysis: a Prospective Observational, Multi-center Study
Source: ClinicalTrials.gov · Last updated 20 Jul 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
OCT-A and eco-colordoppler are technologies which enable optic nerve head (ONH) blood perfusion detection. The aim of the study is to assess ONH vascular and structural components in optic neuropathies with and without ONH edema or pseudo-edema with OCT-A, and analyze ONH blood-flow with eco-colordoppler.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 70 (estimated)
- First submitted
- 10 Jul 2025
- Start date
- Oct 2025
- Primary completion date
- Oct 2027
- Lead sponsor
- Barboni
- Diseases
- Glaucoma
- NCT number
- NCT07075887
What you commit to
- Study type: Observational
- Planned participants: 70
- From Oct 2025 to the primary completion date, Oct 2027
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- any other ONH disease or neurological /retinal disease impairing the evaluation of the ONH;
- patients affected Alzheimer/Parkinson disease will be considered separately
Other
- evidence of media opacities affecting the quality of the vascular assessment;
Who the study is looking for
- Participant (or parents/legal representative/tutor for minors) is willing and able to give informed consent for participation in the study
- patients affected by acute ONH edema (NAION, papilledema, optic neuritis)
- patients affected by acute pseudoedema (LHON)
- patients affected by chronic pseudoedema (LHON, ODD)
- patients affected by chronic ONH neuropathies (NTG, DOA, WS) non- affected eyes in each optic neuropathy patient
Age in the registry: 12 years to - · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.